Grateful and humbled to receive the DeSousa Award for Best Stroke/Interventional Project for the second consecutive year at @MiamiNeuroRes @UMiamiNeuro. None of this happens in isolation. Thankful for incredible mentors, and the opportunity to keep growing in this field.

New ACTN article: Does combining aggressive antiplatelet and IVT during acute intracranial stenting lead to significant hemorrhagic complications? Our RESISTANT study of 823 patients reveals no synergistic bleeding risk—the joint effect is attenuated. onlinelibrary.wiley.com/doi/…

Our latest RESISTANT Registry subanalysis found that aggressive intraprocedural antiplatelet therapy was not associated with excess hemorrhagic risk in patients undergoing acute intracranial stenting after intravenous thrombolysis. onlinelibrary.wiley.com/doi/…

Check out the April Stroke Alert Podcast @StrokeAHA_ASA, where our study on emergent intracranial stenting strategies (rescue vs first-line) is discussed by @NAsdaghi and @dyavagal ahajournals.org/doi/full/10.…

Intracranial carotid blowout syndrome is rare and often fatal with no predefined management algorithms. Here is our experience-based treatment strategy. Shout out to @romilsingh1892 and @FernandoTerryMD for the hard work! #carotidblowout #endovascular #headandneckcancer #stroke

Check out new publication. Just Published in @TheJNS Therapeutic management of Intracranial ICA Blowout Syndrome (ICABS) — an institutional case series individual participant data meta-analysis. 80 patients analyzed. thejns.org/view/journals/j-n… ICABS is an extremely rare but catastrophic entity. Common causes: • Head & neck cancer invasion • Radiation injury • Iatrogenic injury during transsphenoidal surgery Most frequent location: Petrous ICA (43.8%) Key results: • Bleeding control achieved in 81.2% • Parent vessel sacrifice most common intervention (41%) • Overall complication rate: 35% • Mortality: 27.5% Conservative management had the highest mortality (60%). 📌 Takeaway When acute ICABS occurs → Endovascular therapy could be first-line. Rapid hemorrhage control saves lives. Grateful for learning from mentors @evanluthermd @Starkeneurosurg and collaboration with colleagues @MokshalPorwal @AaronCalienes @matetinihas @joelsequeiros #neuroendovascular #Neurosurgery

Is First-Line Stenting in Patients With Ischemic Strokes Better Than Rescue Stenting? In this #BloggingStroke post, @MaddyRussell16 discusses #Stroke article by @AaronCalienes & @dyavagal et al. #ISC26 @AHAScience ahajournals.org/do/10.1161/b…

Grateful to see our work highlighted by @StrokeAHA_ASA. Important data on first-line vs rescue stenting during EVT for AIS, with comparable safety and effectiveness #ISC26 @dyavagal

We are back at #ISC26 today, presenting more of our work and collaborations. Hope to see you around! @AHAScience @NashwaAbdelhak3 @marcriboj @AaronCalienes @IowaVascular

Looking forward to presenting our work and collaborations at #ISC26 in New Orleans! These are our talks for today!🧠 @IowaVascular @AaronCalienes @NeurologyYale @PwintLThinzar @marcriboj @AHAScience

“Hard to Crack” ICAD-LVO: the hard problem in EVT. Join our advanced session on imaging, thrombectomy strategies, angioplasty, stenting, and ICAD mimics at #ISC26 @AHAScience

ICYMI: Check out the November episode of the #StrokeAlert Podcast. In this episode, host @NAsdaghi addresses these three questions. ahajournals.org/do/10.1161/p… #stroke #StayAlertWithStrokeAlert @NKrementzMD @CT_LP_MRI @AaronCalienes @CerebrovascLab

Honored that our work was featured on the Stroke Alert Podcast! We discuss infarct progression, imaging selection, and outcomes from EVT>24h. Grateful for such an insightful discussion.

In the morning one of our past fellows, @AaronCalienes, started the platform presentations in Caribbean Room 3-5, with this meaningful topic: Endovascular Thrombectomy vs Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 hours: A Systematic Review and Meta-Analysis, recently published in STROKE doi.org/10.1161/STROKEAHA.12… #SVIN #SVIN25 #ORLANDO #UMIAMI #UIOWA

🧠Study of patients who underwent intracranial stenting after EVT found no differences between those with vs. without IVT in: 🗓️90-day mRS shift 🗓️90-day mortality 🕐 24h sICH rates Read more here👇 journals.sagepub.com/doi/abs…

@NguyenThanhMD @StrokeMiami

Our latest study now published in @StrokeAHA_ASA evaluating the benefits of endovascular thrombectomy beyond 24 hours from symptom onset. How does expanding the treatment window could impact stroke care?